Cronos Group Inc. (CRON) Report – Green Future Ahead, Prices Approaching Breakout
This report outlines the development of a five month long bullish continuation pattern that formed within a predominant uptrend. It discusses factors that may lead to a bullish trigger in the near term. Money management objectives are outlined including, trigger, target, and protective stops.
Cronos Group is engaged in investing in companies either licensed, or actively seeking a license, to produce medical marihuana pursuant to the Marihuana for Medical Purposes Regulations ("MMPR"). Co., through its subsidiary In the Zone, is also engaged in producing medical marihuana in accordance with the regulations of the MMPR.
Orips Research is an independent research firm that specializes in global index, sector and equity strategic analysis, focusing on trends, price patterns and relative strength. We serve technical, fundamental, and quantitative firms, providing market analysis, actionable investment ideas, and customized research. Our low-risk high-return investment opportunities place a strong emphasis on risk management by including price targets, protective stops, support/resistance levels and inflection points. We cater to our client’s interests with high touch services such as, bespoke research, analyst calls, and presentations on any name, sector or industry spanning global markets and inter-market relationships.
Our services are used to generate ideas and enhance existing research by contributing an additional data set. Our proprietary research is straightforward actionable analysis that directly contributes alpha to our client’s returns.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.